Purchase Order 75D30122P13613
Award Date 4/13/22
Potential Completion Date 7/1/22
Potential Value $97K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a for-profit manufacturer of genetic sequencing instruments and reagents. The contract is for the provision of an Illumina MiSeq genomic sequencing system, with a ceiling value of $135,435.37 and a performance period ending on November 30, 2015. The order does not have a set-aside designation. Illumina has previously received prime federal contract awards from agencies...
- This is a firm fixed price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract is for the provision of a MiSeq system, a DNA sequencing instrument, at a ceiling value of $95,931.00. The contract does not have a set-aside designation. Illumina has previously been awarded other prime federal contracts and sub-grants to provide sequencing...
- This is a $94,050.00 firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of sequencing and analysis instruments and reagents. The award is for an Illumina MiSeq sequencing system and does not have a set-aside designation. Illumina has a history of providing sequencing equipment and services to support research and diagnostics across various federal agencies, including the National Institutes of Health, Department of...
- This is a firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc. for the provision of MiSeq sequencer and MiniSeq system equipment. The total ceiling value of the contract is $144,985.50, with a period of performance ending on May 9, 2016. Illumina is a manufacturer of genetic and genomic analysis instruments and reagents, and has previously provided sequencing systems and related products to support research and diagnostics at various...
- This is a firm fixed price purchase order awarded by the U.S. Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents, for a MiSeq System. The $131,966.00 contract has a period of performance ending on July 31, 2016. Illumina has provided sequencing systems and services to various federal agencies in the past, including the National Institutes of Health, Department of Agriculture, and Department of Veterans Affairs, to...
- This is a firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of genetic sequencing systems and reagents. The contract is for MiSeq and MiniSeq sequencing systems and reagents, with a ceiling value of $132,300.66 and a period of performance through August 31, 2016. This contract does not have a set-aside designation. Illumina has a history of providing sequencing instruments, reagents, and related services to federal...
- This is a firm fixed price contract awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc. for the provision of a MiSeq sequencing system with a one-year maintenance plan. The total potential value of the contract is $111,870.37. Illumina, a manufacturer of genomic sequencing instruments and reagents, has provided similar sequencing systems and related products to various federal agencies in the past, including the National Institutes of Health (NIH), Department of...
- This firm fixed price purchase order contract was awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc. for the provision of MiSeq Sequencing Kits. The total ceiling value of the contract is $184,230.65, with a completion date of October 10, 2024. The contract is not set-aside. The MiSeq Sequencing Kits are being procured to support the CDC's surveillance, outbreak, and research activities for strain characterization of streptococcal pathogens. Obtaining...
- This is a firm fixed price Blanket Purchase Agreement (BPA) call awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc. for the provision of an Illumina MiSeq System, a genomic sequencing platform. The contract has a ceiling value of $96,401.25 and a completion date of August 30, 2018. Illumina is a manufacturer and provider of sequencing and array-based solutions for genetic and genomic analysis, and has provided a range of sequencing systems and associated products...
- This is a firm fixed price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The contract has a ceiling value of $77,888.22 and will support the delivery of HI-/MI-SEQ KITS with a period of performance ending on September 30, 2016. The contract does not have a set-aside designation. Illumina has previously received prime federal contract awards from agencies such...